Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , Aug. 16, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on August 15, 2019 , the independent directors approved nine equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to nine individuals entering into
View HTML
Toggle Summary New Publication Highlights Transient Increases in Creatinine or Tubular Injury Markers in Heart Failure Patients Should Not Dissuade Use of Ultrafiltration
EDEN PRAIRIE, Minn. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (Nasdaq: CHFS) announced today the publication of a study in Circulation Heart Failure 1 highlighting the benefits of decongestion outweigh concerns from previous studies that showed a rise in creatinine levels or tubular
View HTML
Toggle Summary CHF Solutions, Inc. Announces 53 Percent Increase in Revenues for Second Quarter 2019 Over Previous Year and 38 Percent Increase from Q1 2019
EDEN PRAIRIE, Minn. , Aug. 06, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven alternative to diuretics for the treatment of fluid overload,  announced today its results for the second
View HTML
Toggle Summary CHF Solutions, Inc. To Announce Second Quarter 2019 Financial Results and Corporate Update on August 6, 2019
EDEN PRAIRIE, Minn. , July 30, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its second quarter 2019 financial results will be released on Tuesday, August 6, 2019 . The company will host a conference call and webcast at 9:00 AM ET that morning, during which
View HTML
Toggle Summary CHF Solutions To Exhibit At the American Association of Heart Failure Nurses 15th Annual Meeting
EDEN PRAIRIE, Minn. , June 25, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced it will be exhibiting at the 15 th Annual Meeting of the American Association of Heart Failure Nurses (AAHFN) June 27-29, 2019 at the JW Marriott Austin in Austin, Texas .
View HTML
Toggle Summary CHF Solutions Sponsored AATS Session on Post-Cardiac Surgery, Highlighting Benefits of Using the Aquadex FlexFlow® System Following Cardiac Surgery
The Session, Titled “Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Management Strategies” Moderated by Daniel Beckles, M.D., Ph.D., Highlighted Benefits Such as More Rapid Recovery, Ease of Use, Decrease in Mortality and Increase in Availability of Hospital Resources as Among
View HTML
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , May 29, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on May 23, 2019 , the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals entering into
View HTML
Toggle Summary CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Beebe Healthcare
EDEN PRAIRIE, Minn. , May 15, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announces that Sussex County, Delaware -based health system, Beebe Healthcare , has initiated offering ultrafiltration therapy using the company’s Aquadex FlexFlow system.
View HTML
Toggle Summary CHF Solutions, Inc. Announces 17 Percent Increase in Revenues for First Quarter 2019 Over Previous Year and Provides Company Update
EDEN PRAIRIE, Minn. , May 07, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the first quarter ended March 31, 2019 , which included the following highlights: Revenue for first quarter ended March 31, 2019 was $1.2 million , an increase of 17 percent
View HTML
Toggle Summary CHF Solutions Welcomes Industry Veteran Nestor Jaramillo as Chief Commercial Officer
EDEN PRAIRIE, Minn. , May 06, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announces it has hired Nestor Jaramillo, Jr. as its new chief commercial officer, effective May 7, 2019 . “Nestor has been a key player in medical device commercialization for more than 20 years and has led
View HTML